1Dennis J,Buchanan M D,John Schlaerth M D,et al.Primary vaginal melanoma Thirteen -year disease-free survival after wide local excision and review of recent literature[J].Am Obstet Gynecol,1998,178(3):1177.
2Furuta M,Suto H,Nakamoto S,et al.MRI of malignant melanoma of liver[J].Radiat Ned,1995,13:143-145.
3De la Pava S,Nigogosyan G,Pickren J W,et al.Melanosis of the esophagus[J].Cancer,1963,16:48-50.
4Falkson C I,Ibrahim J,Kirkwood J M,et al.Phase Ⅲ trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma:an Eastern Cooperative Oncology Group study[J].J Clin Oncol,1998,16(5):1743-1751.
5Avril M F,Aamdal S,Grob J J,et al.Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma:a phase III study[J].J Clin Oncol,2004,22(60):1118-1125.
6Bedikian A Y,Millward M,Pehamberger H,et al.Bcl-2 antisense(oblimersen sodium)plus dacarbazine in patients with advanced melanoma:the Oblimersen Melanoma Study Group[J].J Clin Oncol,2006,24(29):4738-4745.
9Pate1 JC. A melanosarcoma of the liver. Presse Med, 1963, 71:2108.
10Boj E. Case of primary malignant melanoma of the liver according to world literature; review and critical evaluation of cases of primary malignant pigmented tumors of the liver. Patol Pol, 1954, 5: 17-24.
